Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Lipoproteins are removed from the plasma by LDL receptor-dependent and -independent pathways. The relative contribution of these has been established for LDL by using modified lipoproteins, but this has not been possible for apoE-rich lipoproteins, such as chylomicron remnants. To do this, we used a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Invest
Hlavní autoři: Choi, S Y, Fong, L G, Kirven, M J, Cooper, A D
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 1991
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295579/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1918372/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115419
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky